Farmacias Guadalajara Expands as Digital Pharmacies Gain Ground

Summary: Corporativo Fragua is expanding Farmacias Guadalajara’s national footprint through new SuperFarmacias and logistics infrastructure, while managing rising labor costs and pressure on operating margins. At the same time, digital pharmacy platforms such as Prixz are gaining ground through nationwide delivery, broader medication catalogs and online access, positioning e-commerce as an increasingly important channel for Mexico’s pharmaceutical retail and healthcare markets. 

Corporativo Fragua is accelerating the expansion of Farmacias Guadalajara across Mexico while digital pharmacy platforms such as Prixz gain market share, highlighting how the country's pharmaceutical retail sector is expanding through both physical infrastructure and e-commerce.

Farmacias Guadalajara closed 2Q2026 with 3,084 stores across 511 cities and all 32 states, after opening 57 locations during the quarter, compared with 47 openings during the same period in 2025. Corporativo Fragua, operator of the pharmacy chain, reported quarterly sales of MX$34.95 billion, a 6.5% increase year-over-year, while same-store sales rose 3.4%.

The company's expansion comes as Mexico's pharmacy market adapts to changing consumer behavior, with established retailers investing in larger physical networks and digital-native companies seeking to capture growing demand for online healthcare and pharmaceutical services.

Physical Expansion Supports National Coverage

Farmacias Guadalajara's store growth remains central to Corporativo Fragua's strategy for 2026. The company plans to open 120 new SuperFarmacias by the end of the year, a pace equivalent to approximately one new store every three days.

In its quarterly report, signed by CEO Javier Arroyo Navarro, the company said its financial position provides sufficient liquidity and reserves to support its store expansion program.

The new locations opened during the second quarter included stores in Baja California, Mexico City, Jalisco, Nuevo Leon, Veracruz and Yucatan. The company also expanded into four additional cities, further extending its national footprint.

As the physical network grows, the company is also increasing the infrastructure required to support a larger store base. Sales floor area increased 4.2% year-over-year to 1.18 million square meters, while customer visits rose 3%.

Corporativo Fragua currently operates a logistics network supported by three distribution centers, five cross-docking facilities, a transportation fleet and its nationwide store network. The company is also developing the Northwest Distribution Center in Hermosillo, Sonora, which is expected to begin operations at the end of 2027.

The investment in distribution infrastructure reflects the operational requirements of maintaining a national physical pharmacy network as the company continues adding stores and expanding into new markets.

Sales Growth Continues Despite Margin Pressure

While store expansion supported revenue growth during the quarter, Corporativo Fragua faced increasing pressure on profitability as operating costs rose and consumer spending moderated.

During the first six months of 2026, the company reported consolidated sales of MX$69.62 billion, representing a 6.8% increase compared with the same period of the previous year.

Quarterly operating income reached MX$2.1 billion, down 7.4% year-over-year. The operating margin declined to 6%, compared with 6.9% during the second quarter of 2025. Majority net income totaled MX$1.22 billion, representing a 1.9% decline.

The company attributed the moderation in profitability to weaker consumer spending in Mexico and higher labor costs. Operating expenses reached MX$7.05 billion during the quarter, equivalent to 20.2% of net sales, compared with 19.5% a year earlier.

Corporativo Fragua ended the quarter with 65,744 permanent employees, an increase of 2,444 workers over the previous 12 months.

The results illustrate a challenge facing large-format retailers across Mexico: maintaining aggressive expansion while managing rising operating costs. For pharmacy operators, the challenge is particularly significant because expansion requires investments not only in stores but also in inventory, distribution capacity and personnel.

Digital Pharmacies Target Growing Online Demand

As established pharmacy chains continue expanding their physical presence, digital-first companies are pursuing a different model focused on national delivery, broader product catalogs and online access.

Mexican digital pharmacy startup Prixz reported triple-digit cumulative growth through 2025 and is positioning itself to capture a larger share of Mexico's growing digital healthcare market.

At a Feb. 10 press conference, Prixz co-founder and Digital Director Sergio "Checo" Pérez said the company had recorded cumulative growth of 300% since 2022. Prixz ended 2025 with more than 7 million website visits and a catalog of approximately 15,000 medications, reported MBN. 

The company now dispatches more than 10,000 orders per day and reaches 98.7% of Mexico's territory, according to the company.

Founded in 2020 as a fully digital operation without physical stores, Prixz represents a growing segment of Mexico's pharmaceutical market built around e-commerce rather than traditional retail infrastructure. The company said it was valued at more than US$100 million during its most recent funding round and is backed by Mexican and Silicon Valley investors.

Prixz estimates that it holds approximately 4% of Mexico's digital pharmacy market and ranks as the third-largest pharmacy platform by online traffic, based on external audience measurement data.

Chronic Disease Creates Opportunity for Digital Health

The expansion of digital pharmacies is closely connected to persistent healthcare access challenges, particularly for patients requiring recurring medications for chronic diseases.

Prixz said patients in Mexico visit an average of 2.9 physical pharmacies to complete a prescription, partly because traditional pharmacies typically stock approximately 3,000 medications. The broader national pharmaceutical market includes between 15,000 and 18,000 available products.

These challenges can become more significant outside Mexico's largest metropolitan areas, where pharmacy inventories may be more limited and patients can face longer travel distances.

According to data presented by Prixz, patients spend an average of 70 minutes obtaining a prescription through traditional channels, including transportation and time spent waiting at pharmacies.

Digital platforms are seeking to address these gaps by offering larger catalogs and direct delivery. This model could become increasingly relevant as Mexico's population manages a growing burden of chronic diseases.

National health data referenced by Prixz show that 18.3% of Mexico's adult population lives with diabetes, while nearly one-third has hypertension. Other long-term health conditions include hypercholesterolemia, thyroid disorders, depression and obesity.